Pleural Mesothelioma Patients Needed for Trial of New Drug...
Preliminary tests of the VEGF-inhibitor nintedanib suggest that it can make mesothelioma chemotherapy more effective.(PRWeb July 17, 2017)Read the full story at http://www.prweb.com/releases/2017/07/prweb14512990.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news